Invention Application
- Patent Title: ANTIBODIES FOR CHELATED RADIONUCLIDES AND CLEARING AGENTS
-
Application No.: US17048072Application Date: 2019-04-16
-
Publication No.: US20220031871A1Publication Date: 2022-02-03
- Inventor: Julien TORGUE , Paul JUREK , Federico ROJAS-QUIJANO , Garry E. KIEFER , Olivier FREYTAG , Christian GERDES , Christian KLEIN , Pablo UMANA , Alexander HAAS , Sofia FROST , Amal SAIDI , Tapan NAYAK
- Applicant: Hoffmann-La Roche Inc. , Orano Med SAS
- Applicant Address: US NJ Little Falls; FR Courbevoie
- Assignee: Hoffmann-La Roche Inc.,Orano Med SAS
- Current Assignee: Hoffmann-La Roche Inc.,Orano Med SAS
- Current Assignee Address: US NJ Little Falls; FR Courbevoie
- International Application: PCT/IB2019/000521 WO 20190416
- Main IPC: A61K51/04
- IPC: A61K51/04 ; A61K51/06 ; A61K51/10 ; A61P35/00
Abstract:
The present application relates to antibodies which bind specifically to chelated radionuclides, including bispecific antibodies, It further relates to the use of such bispecific antibodies in applications such as radioimmunoimaging and radioimmunotherapy. It additionally relates to clearing agents and useful in such methods.
Information query
